Interestingly, in several human normal and neoplastic cell lines, including MDA-MB-468 breast cancer cells, impairment of mTOR pathway by rapamycin was found to inhibit cell motility or invasion (Zhou and Huang, 2011). This evidence concerns the gene MTOR and breast carcinoma.